Pulmonary status of habitual cocaine smokers

We determined the prevalence of respiratory symptoms and lung dysfunction in a large sample of habitual smokers of freebase cocaine ("crack") alone and in combination with tobacco and/or marijuana. In addition, we compared these findings with those in an age- and race-matched sample of nonusers of crack who did or did not smoke tobacco and/or marijuana. A detailed respiratory and drug use questionnaire and a battery of lung function tests were administered to (1) a convenience sample of 202 habitual smokers of cocaine (cases) who denied intravenous drug abuse and (2) a reference sample of 99 nonusers of cocaine (control subjects). The cocaine smokers (85% black) included the following: 68 never-smokers of marijuana, of whom 43 currently smoked tobacco and 25 did not, and 134 ever-smokers of marijuana (42 current and 92 former), of whom 92 currently smoked tobacco and 42 did not. The control subjects (96% black) included the following: 69 never-smokers of marijuana, of whom 26 currently smoked tobacco and 43 did not, and 30 ever-smokers of marijuana (18 current and 12 former), of whom 21 currently smoked tobacco and 9 did not. Cases smoked an average of 6.5 g cocaine per week for a mean of 53 months. The median time of the most recent use of crack prior to study was 19 days (range less than 1 to 180 days). After controlling for the use of other smoked substances, frequent crack use was associated with: (1) a high prevalence of at least occasional occurrences of acute cardiorespiratory symptoms within 1 to 12 h after smoking cocaine (cough productive of black sputum [43.7%], hemoptysis [5.7%], chest pain [38.5%], usually worse with deep breathing, and cardiac palpitations [52.6%]) and (2) a mild but significant impairment in the diffusing capacity of the lung.(ABSTRACT TRUNCATED AT 250 WORDS)

Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity

PURPOSE

Abnormalities in pulmonary function have been reported in association with chronic liver disease of varied etiology. The aim of this study was to better define the frequency and nature of these abnormalities in patients who were being evaluated for liver transplantation.

PATIENTS AND METHODS

We performed a battery of pulmonary function tests and chest radiographs in 116 consecutive patients (50 men, 66 women; aged 19 to 70 years, mean 44.6 years) with severe advanced liver disease who were hospitalized specifically for evaluation for possible orthotopic liver transplantation and were able to perform technically satisfactory tests. In 17 patients, quantitative whole-body technetium-99m macroaggregated albumin perfusion scanning was also performed for assessment of possible right-to-left shunting through intrapulmonary vascular dilatations.

RESULTS

The most commonly affected test of lung function was the single-breath diffusing capacity for carbon monoxide (DLCO), which was abnormal in 48%, 45%, and 71% of patients who never smoked, former smokers, and current smokers, respectively. Ventilatory restriction was noted in 25% of all patients, airflow obstruction (reduced ratio of forced expiratory volume in 1 second to forced vital expiratory volume in 1 second to forced vital capacity) in only 3%, and a widened alveolar-arterial oxygen gradient in 45%. Diffusion impairment was accompanied by a restrictive defect in only 35% of the patients and by an abnormally widened alveolar-arterial oxygen gradient in 60%. When diffusion impairment was accompanied by an oxygenation defect, it was also associated with a significantly increased right-to-left shunt fraction (mean 24.9%) assessed from quantitative whole-body perfusion imaging. On the other hand, isolated diffusion impairment unaccompanied by significant hypoxemia (noted in approximately a third of the patients with a reduced DLCO) was not associated with evidence of significant intrapulmonary shunting (mean right-to-left shunt fraction 6.7%).

CONCLUSIONS

Most patients with advanced liver disease have one or more types of abnormality in lung function, a reduced DLCO being the single most common functional defect. Mechanisms accounting for the abnormality in gas transfer may include intrapulmonary vascular dilatations, diffuse interstitial lung disease, pulmonary vaso-occlusive disease, and/or ventilation-perfusion imbalance.

Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity

PURPOSE

Abnormalities in pulmonary function have been reported in association with chronic liver disease of varied etiology. The aim of this study was to better define the frequency and nature of these abnormalities in patients who were being evaluated for liver transplantation.

PATIENTS AND METHODS

We performed a battery of pulmonary function tests and chest radiographs in 116 consecutive patients (50 men, 66 women; aged 19 to 70 years, mean 44.6 years) with severe advanced liver disease who were hospitalized specifically for evaluation for possible orthotopic liver transplantation and were able to perform technically satisfactory tests. In 17 patients, quantitative whole-body technetium-99m macroaggregated albumin perfusion scanning was also performed for assessment of possible right-to-left shunting through intrapulmonary vascular dilatations.

RESULTS

The most commonly affected test of lung function was the single-breath diffusing capacity for carbon monoxide (DLCO), which was abnormal in 48%, 45%, and 71% of patients who never smoked, former smokers, and current smokers, respectively. Ventilatory restriction was noted in 25% of all patients, airflow obstruction (reduced ratio of forced expiratory volume in 1 second to forced vital expiratory volume in 1 second to forced vital capacity) in only 3%, and a widened alveolar-arterial oxygen gradient in 45%. Diffusion impairment was accompanied by a restrictive defect in only 35% of the patients and by an abnormally widened alveolar-arterial oxygen gradient in 60%. When diffusion impairment was accompanied by an oxygenation defect, it was also associated with a significantly increased right-to-left shunt fraction (mean 24.9%) assessed from quantitative whole-body perfusion imaging. On the other hand, isolated diffusion impairment unaccompanied by significant hypoxemia (noted in approximately a third of the patients with a reduced DLCO) was not associated with evidence of significant intrapulmonary shunting (mean right-to-left shunt fraction 6.7%).

CONCLUSIONS

Most patients with advanced liver disease have one or more types of abnormality in lung function, a reduced DLCO being the single most common functional defect. Mechanisms accounting for the abnormality in gas transfer may include intrapulmonary vascular dilatations, diffuse interstitial lung disease, pulmonary vaso-occlusive disease, and/or ventilation-perfusion imbalance.

Dental patient reaction to electrocardiogram screening

Ninety-one patients receiving routine dental treatment at the University of Minnesota School of Dentistry participated in an electrocardiogram screening study. The purpose of the study was to evaluate patient reaction to electrocardiogram screening in a dental school clinic. The vast majority of patients indicated the test was easy and did not intrude on the dental appointment. Most of the patients reported that the test was a valuable service and should be available in the dental office. None of the patients indicated that the tests should not be performed in the dental office. Few patients expressed any significant concern or anxiety about the test either before or after it was completed. Twenty-six percent (24/91) of the patients were found to have a cardiac arrhythmia; however, most of these were nonserious arrhythmias (18/24) and would not have had an impact on planned dental procedures. Six patients were identified with arrhythmias that required medical referral before dental treatment was started.

Ventilatory and diffusion abnormalities in potential heart transplant recipients

Few data are available concerning pulmonary function in patients with severe chronic congestive heart failure. Of 315 patients evaluated for potential cardiac transplantation at UCLA, 132 underwent pulmonary function tests. The latter patients had severe heart failure with a mean left ventricular ejection fraction of 19 percent and mean cardiac index of 2.1 L/min/m2. Diffusion impairment either alone or combined with restrictive and/or obstructive ventilatory defects occurred in 67 percent of the patients evaluated. Diffusion impairment occurred as the sole abnormality in 31 percent of the patients and in combination with a restrictive ventilatory defect in 21 percent. A reduction in diffusing capacity has not been previously described as a frequent finding in patients with chronic congestive heart failure. In contrast to other studies involving patients with acute heart failure, obstructive ventilatory defects were uncommon. None of the lung function abnormalities was associated with smoking status, prior drug use, chest roentgenographic changes, hemodynamic findings, or clinical features, including duration of congestive heart failure. The mechanism for the diffusion impairment is unclear but could be due to chronic passive congestion with pulmonary fibrosis and/or recurrent pulmonary emboli. Recognition of diffusion impairment as a common finding in patients with severe chronic congestive heart failure who are candidates for heart transplantation is important for proper interpretation of possible post-transplant changes in diffusing capacity due to other causes.

Intraindividual variability in serial measurements of DLCO and alveolar volume over one year in eight healthy subjects using three independent measuring systems

To evaluate intraindividual and between-machine variability in DLCO, one technician performed triplicate measurement of DLCO in eight healthy subjects on three consecutive days using three different systems (Collins [C], Gould [G], SRL [S]) on five separate occasions over the course of 1 yr. For each subject and machine, we calculated the coefficient of variation (CV) of the DLCO and its associated alveolar volume (VA) and inspiratory vital capacity (IVC) over the five different measurement periods using the mean value for each period. CV (in %) for DLCO in each of the eight subjects for each machine varied from 2.4 to 7.1% for machine C, 4.1 to 10.5% for machine G, and 2.5 to 8.7% for machine S. Two-way ANOVA showed significant differences in CV for DLCO and IVC but not for VA across subjects (p less than 0.01) and for DLCO, VA, and IVC across machines (p less than 0.03): CV for DLCO was higher for G than for C or S; CV for VA and IVC was lower for C than for G or S. Multiple regression did not show a significant relationship between within-individual CV for DLCO and that for VA or IVC. We conclude that variability in DLCO measurements is affected by both subject and machine, but, at least in healthy cooperative subjects, it does not appear to be affected by variability in VA or IVC. For the average subject and the two less variable machines we tested, DLCO measurements could vary within the same subject as much as +/- 9.6% (two-tailed 95% confidence interval) with repeated measurements over 1 yr.

Effects of chlorinated benzenes on diatom fatty acid composition and quantitative morphology. IV. Pentachlorobenzene and comparison with trichlorobenzene isomers

Cells of the diatom Cyclotella meneghiniana were exposed in a closed system to 0.095 ppm pentachlorobenzene over a period of 5 days. Changes in fatty acid and morphological percent composition were monitored to determine the effect of the toxicant. The greatest morphological change observed was an increase in lipid volume. Most morphological changes occurred in the 1 hour and 5 day sampling periods. Few changes in morphological characteristics or fatty acid percent composition were observed at eight hours, when the cells were in the dark. The C18:1 and C20:5 fatty acids were most variable with exposure to pentachlorobenzene. Results suggest that at sublethal doses, lipophilic toxicants exert effects that are biphasic. That is, immediately measurable effects are observed in the cells that include increases in storage products and changes in membranous organelles. Long-term effects are postulated to be the result of mobilization of lipophilic toxicants that have partitioned into lipid stores and are more available when lipids are metabolized. Although pentachlorobenzene has a higher octanol/water partition coefficient, it appears to exert fewer cellular changes than any trichlorobenzene isomer.

Metered-dose inhaler usage in subjects with asthma: comparison of Nebulizer Chronolog and daily diary recordings

The Nebulizer Chronolog (NC) is a portable electronic device that attaches to standard metered-dose inhalers (MDIs) and records and stores the date and time of each MDI actuation. We evaluated the long-term performance of the NC and compared its data to concurrent recordings of self-administered MDI usage in daily diaries. Eighty-three subjects with asthma were evaluated during a 7 1/2-month panel study of air pollution effects. Although 44 (53%) of the NCs developed a malfunction during the study, the average total (+/- SD) percentage of useful days with functioning NCs was still 86 +/- 18% (median 93%). The agreement between the daily diary and NC recordings was very high, that is, 50 (67%) of 75 subjects had perfect agreement. Eighteen subjects with over or under diary reporting were detected. We conclude that the NC is an effective, objective, accurate, and continuous monitor of daily MDI usage despite some remediable technical problems. The NC can facilitate the evaluation of short- and long-term medication usage patterns and compliance issues in MDI-related research and clinical settings.

Dental erosion secondary to ethanol-induced emesis

Case reports within the dental literature have attributed dental erosion to many factors. Severe dental erosion from chronic vomiting, induced by ethanol abuse, has not been previously documented. This article reports such a history and reviews appropriate intervention by the dental practitioner.

Respiratory effects of cocaine "freebasing" among habitual users of marijuana with or without tobacco

Use of cocaine by smoking its alkaline precursor ("freebasing") has become increasingly prevalent. Recent studies of small numbers of cocaine users suggest that freebasing frequently causes cough, dyspnea, and abnormalities in diffusing capacity (DCO), although these findings could have been due to concomitant use of other drugs. We therefore evaluated the relationship between cocaine use by freebasing and chronic respiratory symptoms and lung dysfunction in a large sample of habitual smokers of marijuana with or without tobacco who denied intravenous drug abuse. The findings suggested that, among habitual marijuana smokers, "moderate" cocaine smoking damaged both large and small airways, as reflected by functional changes that were independent of concomitant marijuana use and appeared to be synergistic with the effects of tobacco. On the other hand, no adverse influence of cocaine smoking on the pulmonary microcirculation was demonstrated in our sample of freebase users.

Impaired exercise performance and pulmonary function in elite cyclists during low-level ozone exposure in a hot environment

We evaluated the effects of low concentrations of ozone on the exercise performance and pulmonary function of 17 top-caliber endurance cyclists under conditions simulating competition and realistic temperature (31 degrees C). Each subject was randomly exposed to filtered air (FA), 0.12 and 0.20 ppm O3 on separate days in an environmental chamber. Each subject attempted to maintain submaximal exercise on a cycle ergometer equivalent to approximately 70% of maximal oxygen consumption (VO2max) for 60 min, followed by incremented (maximal) exercise until exhaustion. During submaximal exercise, average minute ventilation (VE) (89 L/min), VO2 (51 ml/min/kg or 72% VO2max), work load (260 W), and work time (57 min) were similar across all exposures. During maximal exercise, average peak VE (150 L/min), VO2 (68 ml/min/kg), work load (382 W), and ride time (263 s) were similar between 0.12 ppm O3 and FA. However, significant reductions in peak VE (18%), VO2 (16%), tidal volume (22%), work load (8%), and ride time (30%) occurred in 0.20 ppm O3 compared with those in FA. Postexercise decrements in forced expired volume in one second (FEV1) averaged 5.6% and 21.6% in 0.12 and 0.20 ppm O3, respectively. Ozone-related symptoms were mild in 0.12 ppm O3 but intensified and probably limited maximal performance in 13 subjects in 0.20 ppm O3. Changes in carbon monoxide diffusing capacity (adjusted for alveolar volume) were not significant across exposures. Nine subjects showed histamine hyperresponsiveness (i.e., greater than 20% decrease from the control postdiluent FEV1) after exposure to 0.20 ppm O3 as compared with 1 subject in 0.12 ppm O3.(ABSTRACT TRUNCATED AT 250 WORDS)

The need for psychiatric-dental liaison in the treatment of bulimia

During dental examinations 38% of 66 outpatients with bulimia were found to have evidence of significant enamel erosion, and chronicity of vomiting was significantly associated with erosion. Liaison with colleagues in dentistry is necessary when working with bulimic patients.

Bronchodilator effects of caffeine in coffee. A dose-response study of asthmatic subjects

Although caffeine is a universal drug and has multiple pharmacologic and physiologic actions in man, there are surprisingly few objective data about its effect on pulmonary function. We conducted a short-term, double-blind, randomized crossover study in nine asthmatic adults who ingested decaffeinated coffee containing varying amounts of added caffeine (mean of 0.2,2.5,5.6, and 7.2 mg/kg of body weight) on different days. The subjects also ingested decaffeinated coffee and aminophylline (200 mg) on a separate day of study. Baseline and post-drug determinations of serum levels of caffeine and theophylline, forced expired volume and flow, specific airway conductance (Gaw/VL), vital signs, and reported symptoms were obtained. Peak increases in serum caffeine concentrations (mean, 12.4 micrograms/ml +/- 1.5 micrograms/ml) occurred 45 minutes following the highest dose of caffeine (7.2 mg/kg), whereas the peak theophylline level (mean 3.8 micrograms/ml +/- 0.4 micrograms/ml) occurred 90 minutes following oral administration of aminophylline (mean theophylline, 2.6 mg/kg). Comparable peak increases in the forced expiratory volume in one second (FEV1), the forced expiratory flow during the middle half of the forced vital capacity (FEF25-75%), and Gaw/VL occurred at 120 minutes following aminophylline and the highest dose of caffeine, indicating that caffeine is an effective bronchodilator but is only 40 percent as active as an equivalent molar dose of theophylline. Regression analysis revealed statistically significant dose-response relationships between peak increases in serum caffeine concentrations and increases in FEV1, FEF25-75%, and Gaw/VL from baseline values. These findings have diagnostic and therapeutic implications regarding the use of caffeine prior to tests of pulmonary function and as a dietary agent, alone or in combination with theophylline.

Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction

Increasing hypoxia with altitude ascent is a potentially serious problem for patients with hypoxemic chronic airway obstruction (CAO) at sea level. We developed a hypoxia-altitude simulation test (HAST) to assess acute cardiopulmonary responses to the inhalation of hypoxic gas mixtures (equivalent to the inspired oxygen tension (PO2) present at 5,000, 8,000, and 10,000 feet above sea level) alone and in combination with supplemental oxygen (O2). Twenty-two subjects with stable normocapnic CAO were studied at sea level with a computer-based system that measured on-line, breath-by-breath resting ventilatory and gas exchange variables. Subjects breathed 20.9% (baseline), 17.1, 15.1, 13.9, and 20.9% (recovery) O2, and measurements were obtained once a "steady state" was reached at each level. Steady-state arterial PO2 (PaO2) and O2 saturation, alveolar PO2, and alveolar-to-arterial PO2 gradient decreased markedly during successive hypoxic levels, whereas arterial carbon dioxide tensions decreased only modestly. Minute ventilation and heart rate during 13.9% O2 increased only 12 and 10% above baseline. Ten subjects had asymptomatic cardiac arrhythmias during the HAST. Supplemental O2 significantly improved nearly all physiologic indexes. Sea level PaO2 best predicted acute, resting altitude PaO2. Sea level PaO2 values of 68 and 72 mmHg successfully classified more than 90% of the subjects with a PaO2 greater than 55 mmHg at 5,000 feet and a PaO2 greater than 55 mmHg at 8,000 feet, respectively. A regression equation and nomogram were derived to estimate PaO2 at altitudes between 5,000 to 10,000 feet in patients with normocapnic CAO.(ABSTRACT TRUNCATED AT 250 WORDS)

Acute and subacute bronchial effects of oral cannabinoids

The bronchodilating activity of oral cannabinoids was evaluated in three double-blind experiments that involved the study of dose-response and interactive relationships and the potential development of tolerance. Data indicated that delta 8-tetrahydrocannabinol (delta 8-THC), cannabinol (CBN), and cannabidiol (CBD) in maximal doses of 75 mg, 1200 mg, and 1200 mg, respectively, did not induce significant dose-related physiologic effects in experienced marijuana smokers. delta 8-THC (75 mg) was, however, associated with bronchodilation, tachycardia, and peak highs less than that after delta 9-tetrahydrocannabinol (delta 9-THC). The combinations of CBN and CBD with low-dose delta 9-THC (5 mg) did not induce significant bronchodilation but did exert interactive effects on heart rate and "high." A 20-day study of daily delta 9-THC (20 mg), CBN (600 mg), and CBD (1200 mg) did not indicate tolerance or reverse tolerance to any drug. We conclude that delta 9-THC and, to a lesser extent, delta 8-THC, have acute bronchodilator activity but that CBN, CBD, and their combinations do not provide effective bronchodilation. The daily use of delta 9-THC was not associated with clinical tolerance.

Respiratory symptoms of flight attendants during high-altitude flight: possible relation to cabin ozone exposure

The smaller size and lighter weight of the Boeing 747SP aircraft, introduced into passenger service in 1976, permitted higher-altitude flight than older commercial aircraft and thus potentially greater ozone exposure for those of board. Concerned flight attendants distributed questionnaires relating to symptoms experienced on the Boeing 747SP and/or conventional 747 aircraft to Los Angeles- and New York-based flight attendants. Respondents reported symptoms by frequency and severity and by in-flight and after-flight occurrence. Based on the assessment of three health scientists as to ozone-relatedness, the frequency of "definite" and "probable" ozone-related symptoms of any severity reported by both groups of attendants was significantly associated with 747SP flights (chi-squares: P less than 0.05). After-flight symptoms significantly associated with 747SP experience, although fewer in number than in-flight symptoms, were all in the scientists' "definite" category. In 21 flight attendants who complained of moderate to severe symptoms during 747SP flights, a battery of pulmonary function tests performed approximately two weeks after their last 747SP flight failed to reveal abnormalities. The symptom questionnaire results are consistent with possible exposure of cabin attendants to toxic levels of ozone during the higher-altitude flights of the Boeing 747SP compared to conventional 747 aircraft.

The UCLA population studies of chronic obstructive respiratory disease. 5. Agreement and disagreement of tests in identifying abnormal lung function

The relative sensitivity and specificity of symptoms, spirometry, the flow-volume (FV) curve, the single-breath nitrogen test (SBNT), and specific airway conductance (SGaw) were estimated by cross comparison of these tests with the FEV1/FVC ratio and other tests in 1,201 residents of Los Angeles. Spirometry and the flow-volume curve were estimated to be the most sensitive, yet reasonably specific composite measures, and FEV1/FVC and V75 to be the most sensitive individual indices. Among current smokers, FEV1/FVC was more frequently abnormal (23 percent) than FEF25-75% (16 percent), showed higher concordance with an abnormal FEF25-75% (88 percent), and identified a greater percentage of individuals as abnormal when the FEF25-75% was normal (9 percent) than vice versa. SGaw and SBNT showed a poor concordance with FEV1/FVC and identified more individuals as abnormal who had a normal FEV1/FVC. Although the proportion of current smokers with productive cough was relatively high (26 percent), none of the function tests showed a reasonable concordance with this symptom. These findings suggest that: 1) spirometry, the flow-volume curve, V75 and FEV1/FVC are relatively sensitive and specific indicators of respiratory impairment; 2) spirometry and the FV curve provide similar but not completely overlapping information; 3) SGaw and SBNT yield different (or less specific) information than the other tests; and 4) effects of cigarette smoking identified by productive cough are different from those identified by other tests.

Residents' training goals in respiratory knowledge and skills: perspective of three parties

Medical residents, full-time respiratory teaching staff, and community-based doctors rated the importance of fifty-five respiratory training goals involving knowledge and skills necessary for the future practices of all medical residents. Residents also rated their perceived preparedness in these training areas. Intra- and inter-group analyses indicated that residents agreed more often, and consistently assigned more importance (94% of goals) to the training goals, than did the teachers and doctors. Although the residents considered themselves prepared for 69% of the training goals, they also had moderate intra-group disagreement. These results may reflect variable training experiences and/or institutional practices, but areas of less than adequate preparation were identified and can be corrected. The other two groups were in general agreement except regarding some clinical skills. This study offers possible explanations for the group responses and indicates the potential benefit for groups to discuss, identify, and survey training goals.

Survey of hospital doctors' training goals in diagnosis and management of pulmonary diseases

Although subspecialty training goals for junior hospital doctors have not been evaluated, they are potentially useful for assessing clinical competence. A questionnaire was sent to medical residents, full-time pulmonary teaching staff, and community-based physicians who were asked to rate the importance of diagnosing and managing selected pulmonary diseases for the future practices of young hospital doctors. The latter also rated their perceived preparedness for the same training goals. Generally good intra- and intergroup agreement about the relevance of most of the training goals was observed, although the hospital doctors rated a greater number of items to be more important than did the two other groups. This finding may be attributed to institutional influences and to many clinical abilities expected of all physicians. Immunological or fibrotic and paediatric respiratory disorders were rated least important by most respondents. The hospital doctors disagreed on the basis of the distribution of their ratings about their preparedness for the same goals, which probably reflects varying training experiences and background. The process of developing general professional training goals in a subspecialty requires discussion, identification, and consensus to identify and potentially correct areas of weakness, with allowance for institutional training patterns. A survey such as described in this study can provide data that can help measure clinical competence and support or define curricular changes.

Respiratory status of seventy-four habitual marijuana smokers

Previous studies of the long-term effects of habitual marijuana smoking on respiratory status and lung function have yielded conflicting results. In the present study, lung function tests obtained in 74 regular marijuana smokers (duration of smoking > two-five years; frequency of smoking three days/week to several times/day) who denied intravenous narcotic drug abuse were compared with similar tests performed in two groups of control subjects. One group consisted of individuals tested in a mobile laboratory who were computer-matched to the marijuana smokers for anthropometric characteristics and quantity and duration of tobacco smoking; the other group was comprised of 41 nonsmokers of marijuana who were tested in the same laboratory as the marijuana smokers. Paired and unpaired t analyses revealed lower values for specific airway conductance (-0.07 to -0.08 +/- 0.02; P < 0.001) in the marijuana smokers compared with either group of control subjects, but no differences in spirometric indices, closing volume or delta N2 750-1250. When non-tobacco smoking marijuana users (n = 50) were matched with either non-tobacco smoking or tobacco smoking control subjects, significant differences were again noted in specific airway conductance (P < 0.001) but not in spirometric tests, closing volume or delta N2 750-1250. These results suggest that habitual smoking of marijuana may cause mild, but significant, functional impairment predominantly involving large airways which is not detectable in individuals of the same age who regularly smoke tobacco. The clinical implications of these findings await further study.